- Home
- LPTH vs PRGO Comparison
LPTH vs PRGO Comparison
Compare LPTH & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- PRGO
- Stock Information
- Founded
- LPTH 1985
- PRGO 1887
- Country
- LPTH United States
- PRGO Ireland
- Employees
- LPTH N/A
- PRGO 9140
- Industry
- LPTH Semiconductors
- PRGO Biotechnology: Pharmaceutical Preparations
- Sector
- LPTH Technology
- PRGO Health Care
- Exchange
- LPTH Nasdaq
- PRGO Nasdaq
- Market Cap
- LPTH N/A
- PRGO 3.5B
- IPO Year
- LPTH 1996
- PRGO 1991
- Fundamental
- Price
- LPTH $2.69
- PRGO $25.76
- Analyst Decision
- LPTH Strong Buy
- PRGO Buy
- Analyst Count
- LPTH 2
- PRGO 4
- Target Price
- LPTH $3.00
- PRGO $37.00
- AVG Volume (30 Days)
- LPTH 364.5K
- PRGO 1.3M
- Earning Date
- LPTH 02-06-2025
- PRGO 11-06-2024
- Dividend Yield
- LPTH N/A
- PRGO 4.29%
- EPS Growth
- LPTH N/A
- PRGO N/A
- EPS
- LPTH N/A
- PRGO N/A
- Revenue
- LPTH $32,049,325.00
- PRGO $4,392,000,000.00
- Revenue This Year
- LPTH $12.63
- PRGO N/A
- Revenue Next Year
- LPTH $16.80
- PRGO $4.51
- P/E Ratio
- LPTH N/A
- PRGO N/A
- Revenue Growth
- LPTH N/A
- PRGO N/A
- 52 Week Low
- LPTH $1.04
- PRGO $23.89
- 52 Week High
- LPTH $2.86
- PRGO $34.60
- Technical
- Relative Strength Index (RSI)
- LPTH 84.03
- PRGO 36.42
- Support Level
- LPTH $2.36
- PRGO $25.16
- Resistance Level
- LPTH $2.86
- PRGO $28.62
- Average True Range (ATR)
- LPTH 0.23
- PRGO 0.66
- MACD
- LPTH 0.09
- PRGO -0.35
- Stochastic Oscillator
- LPTH 84.68
- PRGO 15.79
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.